Abstract
Letters1 June 1991Requiem for Gold?Luis Fernandez-Herlihy, MDLuis Fernandez-Herlihy, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-114-11-993_3 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the Editors:The time has come to stop the use of injectable (or any other) gold in the treatment of adult rheumatoid arthritis. The recent report by Epstein and colleagues (1) on the apparent ineffectiveness of parenteral chrysotherapy is highly significant. Since the first reports of the use of gold therapy in rheumatoid arthritis, 64 years ago, its efficacy has been hotly debated and its toxicity has been amply documented. A recent study (2) found that of six commonly used second-line drugs for the treatment of rheumatoid arthritis (methotrexate, injectable gold, D-penicillamine, sulfasalazine, auranofin, and antimalarials), injectable gold had...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
